Lipocine (LPCN) Return on Capital Employed [ROCE] (2013 - 2025)
Lipocine's Return on Capital Employed [ROCE] came in at -40.99% for Q3 2025, down 14.89 percentage points from -26.10% a year earlier and down 10.15 percentage points from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Return on Capital Employed [ROCE] (2013 - 2025) Analysis & Trends
For FY2024, Lipocine's Return on Capital Employed [ROCE] was -5.44%, up 59.44 percentage points from FY2023.
- Return on Capital Employed [ROCE] carries a five-year change of +78.93 percentage points (FY2019 to FY2024).
- Going back by year, Return on Capital Employed [ROCE] was -64.87% in FY2023 (-36.91 pp), -27.97% in FY2022 (-37.41 pp), 9.45% in FY2021 (+122.47 pp) and -113.03% in FY2020 (-28.66 pp).
- The Q3 2025 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q2 2024.
- Year-over-year, Return on Capital Employed [ROCE] increased in five of the last eight quarters, with an average year-over-year change of +9.80 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q4 2021 (a gain of 105.15 percentage points), and the weakest in Q3 2023 (a drop of 78.74 percentage points).
- Business Quant data shows LPCN's Return on Capital Employed [ROCE] at -30.84% (Q2 2025), -32.01% (Q1 2025) and -5.75% (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Lipocine | 11.11 Mn | -56.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -40.99% |
| Jun 30, 2025 | -30.84% |
| Mar 31, 2025 | -32.01% |
| Dec 31, 2024 | -5.75% |
| Sep 30, 2024 | -26.10% |
| Jun 30, 2024 | -43.30% |
| Mar 31, 2024 | -45.61% |
| Dec 31, 2023 | -84.40% |
| Sep 30, 2023 | -70.53% |
| Jun 30, 2023 | -45.21% |
| Mar 31, 2023 | -39.37% |
| Dec 31, 2022 | -32.93% |
| Sep 30, 2022 | 8.21% |
| Jun 30, 2022 | 6.00% |
| Mar 31, 2022 | 6.72% |
| Dec 31, 2021 | 7.71% |
| Sep 30, 2021 | -38.66% |
| Jun 30, 2021 | -38.14% |
| Mar 31, 2021 | -50.71% |
| Dec 31, 2020 | -97.44% |
API Access
Lipocine Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();